Anton Zahner

GAM Investment Management (Switzerland) AG (GAM Switzerland) is an asset management firm headquartered in Zurich, Switzerland. The firm was founded in 1983 and is owned by GAM Holding AG (SWX: GAM, ADR: GMHLY). GAM Switzerland provides active investment solutions and products for institutions, financial intermediaries and private investors.

Bank Julius Bär & Co. AG (BJB) is the private banking subsidiary of Julius Bär Gruppe AG (SWX: BAER) in Switzerland. Headquartered in Zurich, BJB was founded in 1890 and provides personal wealth management advice to private clients and family offices.

Swisscanto Fondsleitung AG (Swisscanto) is the wholly-owned fund management subsidiary of State-owned Zurcher Kantonalbank in Switzerland. Formerly known as Swissca Fondsleitung AG, the firm was founded in 1993 as a joint venture between the Swiss Cantonal Banks. Headquartered in Zurich, Swisscanto provides fund management services for the entire Swisscanto Invest fund range and also for various private label funds. Their clients include banks, pension funds, insurance companies, fund management companies and investment foundations.

Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services.

JMA Jürg Maurer Asset Management AG (JMA) is an independent asset management firm headquartered in Zurich, Switzerland. The firm was founded by Jürg Maurer in 2008. JMA manages assets of pension funds, family offices, investment funds, corporations and private individuals.

Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland.

Serafin Asset Management AG is an asset management firm headquartered in Zug, Switzerland. The firm was founded in 2011 as AMG Fondsverwaltung AG. They are a subsidiary of Serafin Asset Management Holding GmbH in Germany. Serafin Asset Management manages several equity funds. They offer specialized investment solutions for different market cycles, which provide additional diversification and interesting sources of supplementary income to their clients' core investments.

Glycemicon AG develops novel nutraceuticals. The company was founded by Nadja Mrosek and Peter Harboe-Schmidt in 2013 and is headquartered in Brugg, Switzerland.